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Abstract: Medulloblastoma is the most common malignant pediatric brain tumor. 
Incidence in adult population is less than 1 %. Medulloblastoma in adult usually between 
20 and 40 years old, which is lateral hemispheric and not midline vermian. Survival rate in 
adult is 67% lower than adolescents is 69% and children is 72%. Location of recurrences 
most commonly presents at posterior fossa, spinal, supratentorial, and bone metastases. 
Recurrences of medulloblastoma in supratentorial ventricular is uncommon. The outcome 
for patients with recurrent medulloblastoma has historically been poor. 37 years old male 
who presented with severe headache gradually. Patient has history of headache 2 months 
ago and gait ataxia 1,5 months ago. Patient had surgery 2 years ago with result of 
hystopathology medulloblastoma. He had irradiation completely 22 months ago. Physical 
examination showed GCS 15 with gait ataxia. Head CT scan show multiple isodense lesion 
intraventricular. Before patient had surgery, Head CT scan showed hiperdense lesion at 
cerebellopontine angle. Seeding medulloblastoma to intraventricular is recurrences which 
have poor prognosis.  Patient had poor condition in few days. Patient died before got 
reriradiation 
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1 Introduction 
Medulloblastoma is the most common malignant pediatric brain tumor. Incidence in adult 
population is less than 1 %.[1] Medulloblastoma in adult usually between 20 and 40 years old, 
which is lateral hemispheric and not midline vermian.[2] Survival rate in adult is 67% lower 
than children is 72%. Location of recurrences most commonly presents at posterior fossa, 
spinal, supratentorial, and bone metastases.[3] Late recurrences of medulloblastoma in 
supratentorial ventricular is uncommon. Recurrent meduloblastoma has poor outcome, although 
gets radiotherapy and chemotherapy.[4] Recurrence of this tumor is well recognized and may 
require salvage therapy. Time to recurrence typically occurs within two years of initial diagnosis 
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in the pediatric population. Tumors that follow Collin’s Law (tumor free period of 9 months 
plus the age at diagnosis) are considered to be cured. However, late recurrence of 
medulloblastoma has been documented in the pediatric population.[5] 
2 Case Report 
37 years old male patient who presented with severe headache gradually. Patient has history of 
headache 2 months ago and gait ataxia 1,5 months ago. Patient had been operated 
ventriculoperitoneal shunt (VP shunt) and resection tumor 2 years ago with result of 
histopathology desmoplatic medulloblastoma. He had cranio-spinal irradiation completely 22 
months ago. He had not complaint after irradiation. Physical examination showed GCS 15 with 






Figure 1. Non contrast CT Scan of brain before surgery shows right  






Figure 2. Non Contrast CT Scan of brain after he had been tumor  












Figure 3. Contrast CT Scan of brain after irradiation shows mixed density  






Figure 4. Non contrast CT Scan of brain 2 years later shows  
multiple isodense lesion intraventricular 
 
3 Discussiom 
Medulloblastoma, a malignant tumor typically arising from the cerebellar vermis in young 
children and lobes in older children, represents 4–8% of all intracranial tumors, and is the most 
common malignant central nervous system tumor of childhood,5 with approximately 80% 
occurring in patients under 15 years of age.6 It accounts for 15–25% of all childhood brain 
tumors in comparison with only 1% of adult intracranial neoplasms, with a slight male 
predominance in both groups.[7] 
Differences in childhood and adult tumors can also be observed in terms of histologic variant. 
Classical histologic presentation of medulloblastoma includes densely-packed primitive cells 
with hyperchromatic nuclei, scant cytoplasm, and nuclear molding.[8]  This classical tumor 
histology is more common in children.7 Homer-Wright rosettes may be seen.[9] Adults are more 
likely to have laterally-located tumors, which more often desmoplastic.[9] Both tumor types 
include markers of neuronal lineage, such as class III beta tubulin and MAP-2 neurofilaments, 
whereas more adult tumors will express GFAP.[10] The anaplastic/large cell variant is more 
frequently seen in older children and adults. 
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Medulloblastoma tends to seed the cerebrospinal fluid resulting in extensive leptomeningeal 
involvement, and treatment therefore requires surgical resection followed by neuro-axis 
radiotherapy and chemotherapy.[11] Recurrence in the pediatric population differs from that 
seen in adults. Age at diagnosis has been shown to be a significant predictor of time until 
relapse.[12] The majorities of pediatric recurrences are within two years of initial diagnosis, and 
are in the posterior fossa.[12] Those with tumor-free period equal to the age at diagnosis plus 
nine months may be considered cured (Collin’s Law).[13] While a good predictor of many 
childhood tumors, there are known exceptions to Collins law for medulloblastoma. However, a 
recent review of 125 patients by Massimino et al., gender, age at diagnosis, metastases, and 
therapeutic protocol were shown to have no prognostic impact.[13] 
In the event of recurrence, relapse at a single site and further out from initial time of diagnosis is 
considered a more favorable prognostic indicator.[14] Recurrences are most common in the 
posterior fossa, followed by spinal, supratentorial and boney metastases.[7] Supratentorial 
dissemination is often found in the subfrontal area and may be due to overly generous radiation 
protection of the orbital roof to prevent irradiation of the cribiform plate, allowing for a nidus of 
recurrence.[14] Late recurrence of  medulloblastoma in the supratentorial ventricular 
compartment is uncommon. We present a case of late recurrent medulloblastoma 13 years after 
initial diagnosis, again validating the need for long term follow-up in the pediatric population 
following diagnosis of medulloblastoma  
4 Conclusion 
Seeding medulloblastoma to intraventricular is recurrences which have poor prognosis. 
Patient died before got reirradiation. Although he had not complaint after surgery and 
first irradiation.  
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